Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P-H Groop

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 8, 2018
Association between diet and measures of arterial stiffness in type 1 diabetes - Focus on dietary patterns and macronutrient substitutionsA J Ahola, D Gordin, C Forsblom, et al.
Acta Endocrinologica|July 1, 1986
Effects of acarbose on the relationship between changes in GIP and insulin responses to meals in normal subjectsP H Groop, L Groop, K J Tötterman, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1986
Relationship between changes in GIP concentrations and changes in insulin and C-peptide concentrations after guar gum therapyP H Groop, L Groop, K J Tötterman, et al.
Acta Diabetologica|December 1, 1995
A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulinN Barzilai, P H Groop, L Groop, et al.
Diabetes Care|July 1, 1997
Immune response to glycated and oxidized LDL in IDDM patients with and without renal diseaseE Korpinen, P H Groop, H K Akerblom, et al.
Annals of Internal Medicine|February 1, 1993
What is the benefit of increasing the sulfonylurea dose?S Stenman, A Melander, P H Groop, et al.
Diabetes, Obesity & Metabolism|July 8, 2011
Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trialV Lukashevich, A Schweizer, Q Shao, et al.
Journal of Internal Medicine|July 1, 2009
Telomere length and progression of diabetic nephropathy in patients with type 1 diabetesF Fyhrquist, A Tiitu, O Saijonmaa, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 1987
The effect of dexamethasone on the enteroinsular axisP H Groop, L C Groop, K J Tötterman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 5, 2015
The impact of smoking on the effect of the rs4972593 genetic variant on end-stage renal diseaseM Feodoroff, V Harjutsalo, C Forsblom, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 8, 2018
Association between diet and measures of arterial stiffness in type 1 diabetes - Focus on dietary patterns and macronutrient substitutionsA J Ahola, D Gordin, C Forsblom, et al.
Acta Endocrinologica|July 1, 1986
Effects of acarbose on the relationship between changes in GIP and insulin responses to meals in normal subjectsP H Groop, L Groop, K J Tötterman, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1986
Relationship between changes in GIP concentrations and changes in insulin and C-peptide concentrations after guar gum therapyP H Groop, L Groop, K J Tötterman, et al.
Acta Diabetologica|December 1, 1995
A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulinN Barzilai, P H Groop, L Groop, et al.
Diabetes Care|July 1, 1997
Immune response to glycated and oxidized LDL in IDDM patients with and without renal diseaseE Korpinen, P H Groop, H K Akerblom, et al.
Annals of Internal Medicine|February 1, 1993
What is the benefit of increasing the sulfonylurea dose?S Stenman, A Melander, P H Groop, et al.
Diabetes, Obesity & Metabolism|July 8, 2011
Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trialV Lukashevich, A Schweizer, Q Shao, et al.
Journal of Internal Medicine|July 1, 2009
Telomere length and progression of diabetic nephropathy in patients with type 1 diabetesF Fyhrquist, A Tiitu, O Saijonmaa, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 1987
The effect of dexamethasone on the enteroinsular axisP H Groop, L C Groop, K J Tötterman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 5, 2015
The impact of smoking on the effect of the rs4972593 genetic variant on end-stage renal diseaseM Feodoroff, V Harjutsalo, C Forsblom, et al.
Pageof 14